CA
NZ
UK
AU
IND
US
Moderna, Inc. (NASDAQ:MRNA) shares were trading near their 52-week high at USD 249.76 on October 21, 2026, up 3.17%. The mRNA medicines company settled its Arbutus and Genevant patent litigation in March, won European authorization for its flu plus COVID vaccine in April, expanded …
National HealthCare (NYSE American:NHC) shares were trading near their 52-week high at USD 243.49 on October 21, 2026, down 1.79%. The senior health care operator acquired five skilled nursing facilities on June 1 and announced its second quarter 2026 earnings in an August 7 …
Puma Biotechnology (NASDAQ:PBYI) shares were trading near their 52-week high at USD 10.89 on October 21, 2026, up 1.16%. The cancer drug developer repaid the last of its Athyrium debt during the second quarter, then reported second quarter results on August 6 and raised …
Thermo Fisher Scientific (NYSE:TMO) shares were trading near their 52-week high at USD 693.86 on October 21, 2026, up 0.94%. The laboratory science group completed the sale of its microbiology business in the third quarter, then reported third quarter results on October 21 and …
Veeva Systems (NYSE:VEEV) shares were trading near their 52-week high at USD 317.59 on October 21, 2026, down 0.34%. The life sciences software provider bought Ostro in March, filed its fiscal 2027 second quarter report on August 27, and raised its full-year outlook on …
Veradermics Incorporated (NYSE:MANE) shares were trading near their 52-week high at USD 137.17 on October 21, 2026, up 7.91%. The pattern hair loss drug developer went public in February, reported male Phase 2/3 results in April, closed a follow-on offering in May, announced female …
Waters (NYSE:WAT) shares were trading near their 52-week high at USD 456.82 on October 21, 2026, up 3.16%. The laboratory instruments maker completed its combination with the BD Biosciences and Diagnostic Solutions business in February, issued $3.5 billion of senior notes in March, and …
West Pharmaceutical Services (NYSE:WST) shares were trading near their 52-week high at USD 394.97 on October 21, 2026, up 1.59%. The injectable drug packaging maker authorized a $1.0 billion buyback in February, experienced a material cybersecurity attack in May, and reported second quarter 2026 …
Bicara Therapeutics (NASDAQ:BCAX) shares are trading down 1.04% at $18.16, and the stock's 50-day simple moving average has moved below its 200-day, a pattern technical analysts call a death cross. The company has a market capitalization of $1.20 billion.
CapsoVision (NASDAQ:CV) shares are trading up 1.72% at $6.80, and the stock's 50-day simple moving average has moved above its 200-day, a pattern technical analysts call a golden cross. The company has a marketCapitalizationof $361.56 million.
Please wait processing your request...